Regular priceRs. 22.90/ In Pakistan
Nexium 40 mg Tablet is used to treat frequent heartburn, acid reflux, and other stomach problems caused by proton pump inhibitors (PPIs). It helps reduce the amount of acid that you produce from stomach acid. Nexium 40 mg Tablet will not help you if you do not have acid reflux, acid pain, or heartburn. It is also used for the prevention of gastric and duodenal ulcers in children. It is important to take Nexium 40 mg Tablet as directed by your doctor, usually once a day. The recommended dose of Nexium 40 mg Tablet is one tablet taken once a day. Do not take Nexium 40 mg Tablet more than once a day. If you miss a dose, take it as soon as you remember. Do not take a double dose to make up for the missed dose. Take the tablet at the same time daily. Take this medicine regularly as directed by your doctor. To help you remember, take it for as long as your doctor has prescribed it. If the medicine is not working right away, contact you doctor. If you are not sure about any information, talk to your doctor or pharmacist. Once the information is complete, your doctor may tell you to take this medicine for as long as he/she directed. Keep taking this medicine, especially if you have a history of stomach problems, acid reflux disease, or stomach bleeding. Nexium 40 mg Tablet may take longer to work if you are taking it regularly. Tell your doctor if you have heartburn, acid reflux disease, a stomach disorder such as heartburn, or another reason why you may take this medicine. Tell your doctor if you are allergic to any medicines or any other natural or herbal products. Ask your doctor if you are still experiencing symptoms of a heart attack or stroke, or if you have any thoughts you may have ahead of a heart attack or stroke. You may need urgent medical treatment if you are unable to eat or to drink. You may need to use Nexium 40 mg Tablet more than once a day. Tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. Tell your doctor if you are trying to get an increase in your blood pressure. You should not stop taking Nexium 40 mg Tablet if you experience severe dizziness, fainting, or nausea. If you experience any of these or any other problems while taking this medicine, call your doctor immediately. Keep taking this medicine even if you feel well. Do not stop taking this medicine without consulting your doctor. This medicine is only for you if you are prescribed it. Call your doctor if your condition does not improve, or if you develop a chest pain, nausea, or stomach pain while taking Nexium 40 mg Tablet. If you become pregnant while taking Nexium 40 mg Tablet, contact your doctor. Nexium 40 mg Tablet is excreted in human fetal blood. Tell your doctor if you are pregnant or plan to become pregnant. You should not stop taking Nexium 40 mg Tablet without consulting your doctor.
The US prescription drug program is paying for itself $5.8 billion in rebates to the Department of Veterans Affairs (VA), the Department of Health and Human Services (HHS) and the Federal Trade Commission (FTC).
The program also gives VA a share of the cost of drugs it charges patients. It also pays for VA’s marketing and advertising to doctors, nurses and pharmacists. VA officials have said the discounts are designed to reduce costs for VA and the FTC.
The federal government is paying for VA drugs such as Nexium, a prescription painkiller that treats heartburn, acid reflux and pain in the stomach and intestine. It also pays for a number of other drugs including Prevacid, the acid blocker to treat GERD, the first to be approved by the Food and Drug Administration.
In the first half of 2010, the cost of a single tablet of Nexium was $2,000, according to a VA official. The price of Nexium in the second half of 2010 was $3,500, according to a spokesman.
The federal government’s health care program covers the prescription drug drugs. But the program provides only one dose for each patient.
The program also pays for an extra cost of the VA drug programs. The program provides only a limited number of generic versions of the branded drugs. The program also pays for a small number of Medicaid drugs.
The VA’s Medicaid program is not covered by the government. But the program pays for about 30 percent of the cost of Medicaid drugs. This is not covered by the federal government’s program.
The VA has a separate Medicaid program that covers the prescription drugs that the federal government has to treat patients. The VA pays for these drugs from their own pockets. They also cover the cost of other drugs, including the drug to treat cancer and heartburn. The drug cost of a patient is the same regardless of whether he is prescribed Nexium or Prevacid.
VA said it plans to use the drug discounts to reimburse patients for the prescription drug programs.
VA said the program has helped provide more than $5.8 billion in rebates to the Department of Veterans Affairs (VA), the Department of Health and Human Services (HHS) and the Federal Trade Commission (FTC). VA officials said the rebates are designed to help cover the cost of the VA drugs.
“We are pleased to see that the VA has a plan to help provide more drugs to the patients we serve and provide them with more health care benefits,” said Matt Foll, VA’s deputy director for budget and expenditure.
“Our plan for this program is to help provide more drugs to the patients we serve and provide them with more health care benefits,” said James C. Brown, VA’s deputy director for budget and expenditure.
The plan was announced Thursday in a letter to HHS Secretary Tommy Thompson and to the FTC. In a letter to the FTC, the Department of Health and Human Services Secretary, Robert V. Young, said the plan does not have a plan to help provide more drugs to the patients we serve.
“We hope that we have a plan to help provide more drugs to the patients we serve and provide them with more health care benefits,” said Brown. “We will continue to work to assist and encourage all VA beneficiaries to access the prescription drugs they need to treat their illness.”
The VA said the plan will help provide more than $5.8 billion in rebates to the Department of Veterans Affairs (VA) to beneficiaries in the next year.
For example, the VA may be able to help the beneficiaries get their prescription drugs through the federal government’s Medicare program and the Medicaid program. However, the plan will not have a plan to help the beneficiaries get their medications.
The program is not covered by the government. But the VA’s Medicaid program is not covered by the government.
The VA has a separate program that covers the prescription drug drugs. But the program provides only a limited number of generic versions of the branded drugs. The program pays for about 30 percent of the cost of Medicaid drugs.
“The plan is designed to help beneficiaries access more drugs that the government is covering,” Brown said. “These are the drugs that are covered under the plan.”
The plan pays for about 30 percent of the cost of Medicaid drugs.
Nexium® 24HR 20mg Mini Capsules provide lasting relief from frequent heartburn and acid reflux in a 53% smaller capsule (based on volume of the capsule vs Nexium® 24HR Once Daily Dosing Tablet)
Nexium 24 Hour Once Daily Dosing provides lasting relief for frequent heartburn & acid reflux.
Boxed Contents: 14 Mini Capsules Size: 14 Mini Capsules
Do not use:
CAUTION Always read the label. Follow the directions for use.
Each capsule contains Esomeprazole magnesium trihydrate 22.3mg (equivalent to esomeprazole 20mg)
Active Ingredients: Each capsule contains Esomeprazole magnesium trihydrate 22.3mg (equivalent to esomeprazole 20mg)
Adults 18 years, of age and over: Take 1 capsule daily for at least 7 days and up to 14 days.
Swallow the capsule whole with water, with or without food. Do not crush, chew or open the capsule. Not intended for immediate relief. It may take a few days to achieve maximum results.
Do not take for more than 14 days unless directed by a doctor.
USAGE ADVICE The bottle contains a sealed container with silica gel desiccant. Keep the bottle tightly closed to protect from moisture.
SAFETY DIRECTIONS
Carefully read the enclosed leaflet before use.
Ask your doctor or pharmacist before use if you:
STORAGE INSTRUCTIONS Store below 25°C in a cool, dry place. Storage Temperature: Below 25°C.
Read of medicines and other tighters WarningStore below 25°C.
WARNING Do not use:
Pregnancy.
No protection against:
Adults 18 years of age and over: Take 1 capsule daily for at least 7 days and up to 14 days.
Do not take inaddin range (4-8 capsules per dose).
Tell if you are allergic to esomeprazole or any other medicine.
If allergic reactions occur, stop taking and see your doctor right away.
A pharmaceutical company in the US is planning to launch its own version of Nexium, a painkiller that's still on patent protection and has a long history of marketing. The company's new product, Prevacid, will come in a generic form called esomeprazole magnesium, or Z-PZ, for use in patients who have gastroesophageal reflux disease (GERD) and have trouble swallowing tablets. The company will be launching the new product as an exclusively generic version, while the new drug will be made available as a branded product with the generic drug esomeprazole magnesium. The company's current patent will expire at the end of the year. Z-PZ is just one of a group of generics products that are under development for the treatment of GERD, a condition that affects millions of people around the world. It's a good move for Z-PZ, who is the world's biggest drugmaker and a leader in the development of new drugs for GERD, including the anti-anxiety drug Xanax. The drugmaker is working to develop a new formula for the treatment of GERD, known as GERD-associated acid reflux disease (GERAD), which is a chronic medical condition that occurs when stomach acid becomes too strong. Prevacid, which is manufactured by Zydus Pharmaceuticals, was launched by AstraZeneca last month in Europe and is expected to launch in the US in the fourth quarter of this year. It is hoped that the new drug will have a better track record than the older generic versions, which had been under development for about a decade. However, there is some doubt that the new drug will be sold over-the-counter in the US. In fact, the company's patent for Prevacid runs out in the US this month and it's due to expire in May. The US Food and Drug Administration (FDA) has approved its use for the treatment of GERD, although it's unclear whether this is a good indication for the treatment of Z-PZ. The FDA has said that it is unlikely that the Z-PZ is a good indication for the treatment of Z-PZ. Z-PZ's patent expires in 2013 and the company has been marketing its product for about a year in the United States. A new Z-PZ product, called Nexium, will be launched at a later date. The company hopes that the new product will be effective in treating the condition. The company also plans to develop an anti-anxiety medicine called Xanax, which has been approved for the treatment of anxiety disorders. Z-PZ has been on the market since 2001 and is one of the largest generic pharmaceutical companies in the US. In addition, the company also plans to develop its own product for the treatment of GERD, called Nexium-3. These products are also being sold in the United States and Europe and are available in a variety of forms, including tablets, capsules, and oral suspensions. Nexium-3 has been approved in both the United States and Europe and is available in a variety of forms, including a liquid suspension and oral suspensions. AstraZeneca is already selling a generic version of Nexium-3 for the treatment of GERD-associated acid reflux disease. It has a sales force of about 3,000 sales a day. The company also plans to market its own product in the US, called Nexium-5, which is also known by the generic name Esomeprazole. The company has a presence in the United States and Europe. AstraZeneca is working to develop an anti-anxiety drug called Xanax in the United States, which is also known as Xanax. The company has been on the market for about two years in the United States and is working to develop an anti-anxiety drug called Xanax in the US, which is also known by the generic name Z-PZ. The company also plans to market its own product in the US, called Nexium-6, which is also known by the generic name Esomeprazole. The company has a presence in the United States and Europe and is working to market its own product in the United States, called Nexium-7, which is also known by the generic name Z-PZ. AstraZeneca is also developing its own generic version of Nexium for the treatment of GERD-associated acid reflux disease. The company has a presence in the United States and Europe and is working to market its own product in the United States, called Nexium-8. The company has a presence in the United States and Europe and is working to market its own product in the US, called Nexium-9.
Stade de France Pharmacy